HRT Financial’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Sell |
18,257
-52,715
| -74% | -$5.19M | 0.01% | 802 |
|
|
2025
Q1 | $6.57M | Buy |
+70,972
| New | +$6.57M | 0.04% | 282 |
|
|
2024
Q4 | – | Sell |
-13,805
| Closed | -$1.33M | – | 2165 |
|
|
2024
Q3 | $1.33M | Buy |
13,805
+6,652
| +93% | +$642K | 0.01% | 1005 |
|
|
2024
Q2 | $656K | Sell |
7,153
-6,943
| -49% | -$637K | ﹤0.01% | 1085 |
|
|
2024
Q1 | $1.3M | Buy |
14,096
+6,249
| +80% | +$576K | 0.01% | 734 |
|
|
2023
Q4 | $745K | Buy |
+7,847
| New | +$745K | 0.01% | 1055 |
|
|
2023
Q2 | – | Sell |
-9,233
| Closed | -$679K | – | 2216 |
|
|
2023
Q1 | $679K | Sell |
9,233
-9,343
| -50% | -$687K | 0.01% | 1098 |
|
|
2022
Q4 | $1.55M | Buy |
+18,576
| New | +$1.55M | 0.02% | 675 |
|
|
2022
Q3 | – | Sell |
-35,210
| Closed | -$3.7M | – | 2551 |
|
|
2022
Q2 | $3.7M | Buy |
+35,210
| New | +$3.7M | 0.04% | 332 |
|
|
2022
Q1 | – | Sell |
-2,033
| Closed | -$329K | – | 2763 |
|
|
2021
Q4 | $329K | Sell |
2,033
-38,309
| -95% | -$6.2M | ﹤0.01% | 1972 |
|
|
2021
Q3 | $6.01M | Buy |
40,342
+24,401
| +153% | +$3.64M | 0.04% | 245 |
|
|
2021
Q2 | $3.9M | Buy |
15,941
+9,829
| +161% | +$2.41M | 0.04% | 359 |
|
|
2021
Q1 | $1.62M | Buy |
+6,112
| New | +$1.62M | 0.02% | 619 |
|
|
2020
Q4 | – | Sell |
-5,206
| Closed | -$1.23M | – | 1733 |
|
|
2020
Q3 | $1.23M | Sell |
5,206
-25,519
| -83% | -$6.03M | 0.04% | 376 |
|
|
2020
Q2 | $6.1M | Buy |
+30,725
| New | +$6.1M | 0.18% | 93 |
|